Cervical Health

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.

A 13-year randomized trial finds no added benefit from a booster dose in preventing persistent HPV-16 and HPV-18 infections.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

New research reveals increased rates of human papillomavirus infection and cervical cancer in women aged 65 years and older, highlighting the need to reconsider current screening guidelines.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A new study finds that mailing human papillomavirus self-collection kits, especially with patient navigation support, significantly boosts cervical cancer screening rates.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A new study shows that a self-collected cervical cancer screening device is highly accurate, easy to use, and preferred over clinician collection.

The Teal Wand offers FDA-approved, accurate at-home cervical cancer screening for women aged 25 to 65 years, aiming to improve access and comfort while boosting screening rates.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A nurse-led intervention increased HPV vaccination rates among Hispanic adolescents in a rural North Carolina clinic, according to research presented at the 2025 NAPNAP conference.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A new study found that while cervical cancer risks remain low for women who meet screening exit criteria, they increase with age and time since last screening.

Vvax001, a new HPV16 vaccine, offers a potential alternative to surgery for treating precancerous cervical lesions, with promising trial results.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A recent study highlights gaps in cervical cancer screening compliance, with fewer than 50% of human papillomavirus-positive, negative for intraepithelial lesion or malignancy patients receiving recommended follow-up testing within the guideline time frame.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Discover how human papillomavirus self-collection in health care settings could expand cervical cancer screening access while preserving the essential role of ob-gyn care.

A quality improvement project highlights the benefits of starting human papillomavirus vaccination at age 9 years to increase uptake and reduce disparities in cancer prevention across pediatric populations.

Learn about updated cervical cancer screening recommendations, their benefits, and how they address health disparities to improve outcomes for all women.

A recent study highlights the reduced cost-effectiveness of expanding human papillomavirus vaccination to adults aged 27 to 45 years compared to younger groups, though targeted strategies for high-risk subgroups indicate benefits.

Discover how innovative self-collection methods and the BD Onclarity HPV assay are breaking barriers in cervical cancer screening, empowering underserved communities with accessible and accurate care.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

In a recent meta-analysis, the prevalence of human papillomavirus, especially types 16 and 18, were significantly increased among patients with ovarian cancer vs controls.

A CDC report shows varying HPV vaccination rates in US-affiliated Pacific Islands, with only some regions on track to meet the 2030 WHO goal.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A recent study reported an increase in cervical cancer screening rates among people living with HIV when offering a directed initiative alongside standard care, from 54% to 75%.

HPV vaccination coverage in Japan remains critically low despite the resumption of proactive recommendations by the Ministry of Health, Labour, and Welfare, highlighting the need for stronger cervical cancer control measures.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.